Mannan-induced Nos2 in macrophages enhances IL-17-driven psoriatic arthritis by innate lymphocytes

Jianghong Zhong1, Tatjana Scholz2, Anthony C Y Yau1

  • 1Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 171 77, Sweden.

Science Advances
|May 19, 2018
PubMed

Insights

Inducible nitric oxide synthase (NOS2) produces nitric oxide (NO), a key factor in developing psoriasis and psoriatic arthritis. Targeting NOS2 may offer new therapeutic strategies for these inflammatory skin and joint conditions.

Area of Science:

  • Immunology
  • Dermatology
  • Rheumatology

Background:

  • The inducible nitric oxide synthase (NOS2) gene is a risk factor for psoriasis (Ps) and psoriatic arthritis (PsA).
  • Nitric oxide (NO) may play a pathogenic role in PsA, contrasting with the regulatory role of reactive oxygen species (ROS) from macrophages.

Purpose of the Study:

  • To investigate the role of NOS2-derived NO in a mouse model of mannan-induced Ps and PsA (MIP).
  • To examine NOS2 expression in patients with PsA and its contribution to disease pathogenesis.

Main Methods:

  • Utilized a mouse model of mannan-induced Ps and PsA (MIP).
  • Assessed NO levels and NOS2 expression in mice and PsA patient monocytes.
  • Investigated the effects of Nos2 deletion and NOS inhibition on MIP development.

Main Results:

  • NO was detected before disease onset in the MIP model, independent of NADPH oxidase 2.
  • Nos2 deletion or NOS inhibition suppressed MIP, confirming Nos2-derived NO is pathogenic.
  • NOS2 was upregulated in PsA monocytes; Nos2-dependent IL-1α release from macrophages was crucial for IL-17 production and arthritis.

Conclusions:

  • Nos2-derived NO from tissue macrophages promotes PsA development in the MIP model.
  • This contrasts with the protective role of ROS in this model.
  • Findings highlight NOS2 as a potential therapeutic target for PsA.

Related Concept Videos

Introduction to Innate and Adaptive Immunity01:21

Introduction to Innate and Adaptive Immunity

The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
9.9K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
9.4K
Self-Evaluation: Self-Enhancement and Self-Verification03:00

Self-Evaluation: Self-Enhancement and Self-Verification

Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
5.8K
ATP Driven Pumps I: An Overview01:27

ATP Driven Pumps I: An Overview

ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
9.9K
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
266
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
211